BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Calvert PM, Frucht H. The genetics of colorectal cancer. Ann Intern Med. 2002;137:603-612. [PMID: 12353948 DOI: 10.7326/0003-4819-137-7-200210010-00012] [Cited by in Crossref: 132] [Cited by in F6Publishing: 124] [Article Influence: 6.6] [Reference Citation Analysis]
Number Citing Articles
1 Zhang X, Tian L, Li Z, Liu R, Yu J, Liu B. CAMK2N1 has a cancer-suppressive function in colorectal carcinoma via effects on the Wnt/β-catenin pathway. Biochem Biophys Res Commun 2022;626:220-8. [PMID: 35998547 DOI: 10.1016/j.bbrc.2022.08.036] [Reference Citation Analysis]
2 Huskey ALW, Merner ND. An investigation into the role of inherited CEACAM gene family variants and colorectal cancer risk. BMC Res Notes 2022;15:26. [PMID: 35115044 DOI: 10.1186/s13104-022-05907-6] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Yuan X, Xue J, Tan Y, Yang Q, Qin Z, Bao X, Li S, Pan L, Jiang Z, Wang Y, Lou Y, Jiang L, Du J. Albuca Bracteate Polysaccharides Synergistically Enhance the Anti-Tumor Efficacy of 5-Fluorouracil Against Colorectal Cancer by Modulating β-Catenin Signaling and Intestinal Flora. Front Pharmacol 2021;12:736627. [PMID: 34552494 DOI: 10.3389/fphar.2021.736627] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
4 Wang Y, Li Y, Zhou H, Qian X, Hu Y. Syntaxin 2 promotes colorectal cancer growth by increasing the secretion of exosomes. J Cancer 2021;12:2050-8. [PMID: 33754003 DOI: 10.7150/jca.51494] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
5 He X, Yu B, Kuang G, Wu Y, Zhang M, Cao P, Ou C. Long noncoding RNA DLEU2 affects the proliferative and invasive ability of colorectal cancer cells. J Cancer. 2021;12:428-437. [PMID: 33391439 DOI: 10.7150/jca.48423] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
6 Zhu GX, Gao D, Shao ZZ, Chen L, Ding WJ, Yu QF. Wnt/β‑catenin signaling: Causes and treatment targets of drug resistance in colorectal cancer (Review). Mol Med Rep 2021;23:105. [PMID: 33300082 DOI: 10.3892/mmr.2020.11744] [Cited by in Crossref: 1] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
7 Han H, Li H, Zhou J. Long non-coding RNA MIR503HG inhibits the proliferation, migration and invasion of colon cancer cells via miR-107/Par4 axis. Exp Cell Res 2020;395:112205. [PMID: 32738347 DOI: 10.1016/j.yexcr.2020.112205] [Cited by in Crossref: 2] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
8 Li SQ, Yu Y, Zhang Y, Sun YP, Li XX, Su N. The Role of Formyl Peptide Receptor 1 Gene Polymorphisms in Human Colorectal Cancer. J Cancer 2020;11:3580-7. [PMID: 32284754 DOI: 10.7150/jca.36355] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
9 Han S, Wu W, Da M, Xu J, Zhuang J, Zhang L, Zhang X, Yang X. Adequate Lymph Node Assessments and Investigation of Gut Microorganisms and Microbial Metabolites in Colorectal Cancer. Onco Targets Ther 2020;13:1893-906. [PMID: 32184624 DOI: 10.2147/OTT.S242017] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
10 He X, Li S, Yu B, Kuang G, Wu Y, Zhang M, He Y, Ou C, Cao P. Up-regulation of LINC00467 promotes the tumourigenesis in colorectal cancer. J Cancer 2019;10:6405-13. [PMID: 31772673 DOI: 10.7150/jca.32216] [Cited by in Crossref: 14] [Cited by in F6Publishing: 28] [Article Influence: 4.7] [Reference Citation Analysis]
11 Bi J, Huang Y, Liu Y. Effect of NOP2 knockdown on colon cancer cell proliferation, migration, and invasion. Transl Cancer Res 2019;8:2274-83. [PMID: 35116980 DOI: 10.21037/tcr.2019.09.46] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Yuan W, Liu L, Wei C, Li X, Sun D, Dai C, Li S, Peng S, Jiang L. Identification and meta-analysis of copy number variation-driven circadian clock genes for colorectal cancer. Oncol Lett 2019;18:4816-24. [PMID: 31611992 DOI: 10.3892/ol.2019.10830] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
13 Feng W, Gong H, Wang Y, Zhu G, Xue T, Wang Y, Cui G. circIFT80 Functions as a ceRNA of miR-1236-3p to Promote Colorectal Cancer Progression. Mol Ther Nucleic Acids 2019;18:375-87. [PMID: 31648103 DOI: 10.1016/j.omtn.2019.08.024] [Cited by in Crossref: 35] [Cited by in F6Publishing: 44] [Article Influence: 11.7] [Reference Citation Analysis]
14 Yu XJ, Chen G, Yang J, Yu GC, Zhu PF, Jiang ZK, Feng K, Lu Y, Bao B, Zhong FM. Smoking alters the evolutionary trajectory of non-small cell lung cancer. Exp Ther Med 2019;18:3315-24. [PMID: 31602204 DOI: 10.3892/etm.2019.7958] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
15 Yuan W, Li X, Liu L, Wei C, Sun D, Peng S, Jiang L. Comprehensive analysis of lncRNA-associated ceRNA network in colorectal cancer. Biochemical and Biophysical Research Communications 2019;508:374-9. [DOI: 10.1016/j.bbrc.2018.11.151] [Cited by in Crossref: 21] [Cited by in F6Publishing: 30] [Article Influence: 7.0] [Reference Citation Analysis]
16 Pandurangan AK, Divya T, Kumar K, Dineshbabu V, Velavan B, Sudhandiran G. Colorectal carcinogenesis: Insights into the cell death and signal transduction pathways: A review. World J Gastrointest Oncol 2018;10:244-59. [PMID: 30254720 DOI: 10.4251/wjgo.v10.i9.244] [Cited by in CrossRef: 42] [Cited by in F6Publishing: 41] [Article Influence: 10.5] [Reference Citation Analysis]
17 Jia W, Yu T, An Q, Cao X, Pan H. MicroRNA-423-5p inhibits colon cancer growth by promoting caspase-dependent apoptosis. Exp Ther Med 2018;16:1225-31. [PMID: 30116373 DOI: 10.3892/etm.2018.6288] [Cited by in Crossref: 6] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
18 Jia G, Zhang M, Wang K, Zhao G, Pang M, Chen Z. Long non‐coding RNA PlncRNA‐1 promotes cell proliferation and hepatic metastasis in colorectal cancer. J Cell Biochem 2018;119:7091-104. [DOI: 10.1002/jcb.27031] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
19 Battaglia P, Baritono E, Remo A, Vendraminelli R, Conti A. KRAS Mutations and M2PK Upregulation in Stool Samples from Individuals with Positive Fecal Occult Blood Tests Screened for Colorectal Cancer. Tumori 2014;100:122-7. [DOI: 10.1177/030089161410000202] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
20 Asadi M, Shanehbandi D, Zarintan A, Pedram N, Baradaran B, Zafari V, Shirmohamadi M, Hashemzadeh S. TP53 Gene Pro72Arg (rs1042522) Single Nucleotide Polymorphism as Not a Risk Factor for Colorectal Cancer in the Iranian Azari Population. Asian Pac J Cancer Prev 2017;18:3423-7. [PMID: 29286614 DOI: 10.22034/APJCP.2017.18.12.3423] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
21 Lim Y, Yu S, Yun JA, Do IG, Cho L, Kim YH, Kim HC. The prognostic significance of protein arginine methyltransferase 6 expression in colon cancer. Oncotarget 2018;9:9010-20. [PMID: 29507670 DOI: 10.18632/oncotarget.23809] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
22 Shen X, Zuo X, Zhang W, Bai Y, Qin X, Hou N. MiR-370 promotes apoptosis in colon cancer by directly targeting MDM4. Oncol Lett 2018;15:1673-9. [PMID: 29434862 DOI: 10.3892/ol.2017.7524] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
23 Hu ZY, Wang XY, Guo WB, Xie LY, Huang YQ, Liu YP, Xiao LW, Li SN, Zhu HF, Li ZG, Kan H. Long non-coding RNA MALAT1 increases AKAP-9 expression by promoting SRPK1-catalyzed SRSF1 phosphorylation in colorectal cancer cells. Oncotarget 2016;7:11733-43. [PMID: 26887056 DOI: 10.18632/oncotarget.7367] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 7.6] [Reference Citation Analysis]
24 Qu R, Hao S, Jin X, Shi G, Yu Q, Tong X, Guo D. MicroRNA-374b reduces the proliferation and invasion of colon cancer cells by regulation of LRH-1/Wnt signaling. Gene 2018;642:354-61. [PMID: 29128635 DOI: 10.1016/j.gene.2017.11.019] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 3.8] [Reference Citation Analysis]
25 Huang X, Lu S. MicroR-545 mediates colorectal cancer cells proliferation through up-regulating epidermal growth factor receptor expression in HOTAIR long non-coding RNA dependent. Mol Cell Biochem 2017;431:45-54. [PMID: 28364379 DOI: 10.1007/s11010-017-2974-4] [Cited by in Crossref: 21] [Cited by in F6Publishing: 27] [Article Influence: 4.2] [Reference Citation Analysis]
26 Huang YJ, Yang CK, Wei PL, Huynh TT, Whang-Peng J, Meng TC, Hsiao M, Tzeng YM, Wu AT, Yen Y. Ovatodiolide suppresses colon tumorigenesis and prevents polarization of M2 tumor-associated macrophages through YAP oncogenic pathways. J Hematol Oncol. 2017;10:60. [PMID: 28241877 DOI: 10.1186/s13045-017-0421-3] [Cited by in Crossref: 36] [Cited by in F6Publishing: 58] [Article Influence: 7.2] [Reference Citation Analysis]
27 Gao X, Wen J, Gao P, Zhang G, Zhang G. Overexpression of the long non-coding RNA, linc-UBC1, is associated with poor prognosis and facilitates cell proliferation, migration, and invasion in colorectal cancer. Onco Targets Ther. 2017;10:1017-1026. [PMID: 28260919 DOI: 10.2147/ott.s129343] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 4.4] [Reference Citation Analysis]
28 Zhai H, Shi Y, Chen X, Wang J, Lu Y, Zhang F, Liu Z, Lei T, Fan D. CacyBP/SIP promotes the proliferation of colon cancer cells. PLoS One 2017;12:e0169959. [PMID: 28196083 DOI: 10.1371/journal.pone.0169959] [Cited by in Crossref: 7] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
29 Sun L, Xue H, Jiang C, Zhou H, Gu L, Liu Y, Xu C, Xu Q. LncRNA DQ786243 contributes to proliferation and metastasis of colorectal cancer both in vitro and in vivo. Biosci Rep. 2016;36. [PMID: 26934980 DOI: 10.1042/bsr20160048] [Cited by in Crossref: 19] [Cited by in F6Publishing: 25] [Article Influence: 3.2] [Reference Citation Analysis]
30 Hu ZY, Liu YP, Xie LY, Wang XY, Yang F, Chen SY, Li ZG. AKAP-9 promotes colorectal cancer development by regulating Cdc42 interacting protein 4. Biochim Biophys Acta 2016;1862:1172-81. [PMID: 27039663 DOI: 10.1016/j.bbadis.2016.03.012] [Cited by in Crossref: 13] [Cited by in F6Publishing: 21] [Article Influence: 2.2] [Reference Citation Analysis]
31 Tanaka Y, Ito S, Isobe K. Vancomycin-sensitive bacteria trigger development of colitis-associated colon cancer by attracting neutrophils. Sci Rep 2016;6:23920. [PMID: 27050089 DOI: 10.1038/srep23920] [Cited by in Crossref: 14] [Cited by in F6Publishing: 21] [Article Influence: 2.3] [Reference Citation Analysis]
32 Korkmaz G, Horozoglu C, Arıkan S, Gural Z, Sağlam EK, Turan S, Özkan NE, Kahraman OT, Yenilmez EN, Düzköylü Y, Doğan MB, Zeybek U, Ergen A, Yaylım İ. LGALS3 and AXIN1 gene variants playing role in the Wnt/ β-catenin signaling pathway are associated with mucinous component and tumor size in colorectal cancer. Bosn J Basic Med Sci 2016;16:108-13. [PMID: 26894286 DOI: 10.17305/bjbms.2016.721] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
33 Ibrahim T, Yazbeck C, Maalouly G, Baz M, Haddad F, Sabbagh C, Chahine G. TGFBR1*6A polymorphism in sporadic and familial colorectal Carcinoma: a case-control study and systematic literature review. J Gastrointest Cancer 2014;45:441-7. [PMID: 24880985 DOI: 10.1007/s12029-014-9625-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
34 Tao R, Hu S, Wang S, Zhou X, Zhang Q, Wang C, Zhao X, Zhou W, Zhang S, Li C, Zhao H, He Y, Zhu S, Xu J, Jiang Y, Li L, Gao Y. Association between indel polymorphism in the promoter region of lncRNA GAS5 and the risk of hepatocellular carcinoma. Carcinogenesis 2015;36:1136-43. [PMID: 26163879 DOI: 10.1093/carcin/bgv099] [Cited by in Crossref: 71] [Cited by in F6Publishing: 84] [Article Influence: 10.1] [Reference Citation Analysis]
35 Li Z, Zhang X, Yang Y, Yang S, Dong Z, Du L, Wang L, Wang C. Periostin expression and its prognostic value for colorectal cancer. Int J Mol Sci 2015;16:12108-18. [PMID: 26023718 DOI: 10.3390/ijms160612108] [Cited by in Crossref: 24] [Cited by in F6Publishing: 30] [Article Influence: 3.4] [Reference Citation Analysis]
36 Yao HS, Wang J, Zhang XP, Wang LZ, Wang Y, Li XX, Jin KZ, Hu ZQ, Wang WJ. Hepatocyte nuclear factor 4α suppresses the aggravation of colon carcinoma: HNF4α SUPPRESSES COLON CARCINOMA. Mol Carcinog 2016;55:458-72. [DOI: 10.1002/mc.22294] [Cited by in Crossref: 13] [Cited by in F6Publishing: 23] [Article Influence: 1.9] [Reference Citation Analysis]
37 Kim HS, DO SI, Noh BJ, Jeong YI, Park SJ, Kim YW. Expression of phosphorylated extracellular signal-regulated kinase at the invasive front of hepatic colorectal metastasis. Oncol Lett 2015;9:1261-5. [PMID: 25663894 DOI: 10.3892/ol.2015.2874] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
38 Yin D, He X, Zhang E, Kong R, De W, Zhang Z. Long noncoding RNA GAS5 affects cell proliferation and predicts a poor prognosis in patients with colorectal cancer. Med Oncol. 2014;31:253. [PMID: 25326054 DOI: 10.1007/s12032-014-0253-8] [Cited by in Crossref: 121] [Cited by in F6Publishing: 125] [Article Influence: 15.1] [Reference Citation Analysis]
39 Calvo N, Martín MJ, de Boland AR, Gentili C. Involvement of ERK1/2, p38 MAPK, and PI3K/Akt signaling pathways in the regulation of cell cycle progression by PTHrP in colon adenocarcinoma cells. Biochem Cell Biol 2014;92:305-15. [DOI: 10.1139/bcb-2013-0106] [Cited by in Crossref: 11] [Cited by in F6Publishing: 16] [Article Influence: 1.4] [Reference Citation Analysis]
40 Cho SM, Lee EO, Kim SH, Lee HJ. Essential oil of Pinus koraiensis inhibits cell proliferation and migration via inhibition of p21-activated kinase 1 pathway in HCT116 colorectal cancer cells. BMC Complement Altern Med 2014;14:275. [PMID: 25074784 DOI: 10.1186/1472-6882-14-275] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
41 Lu X, Li C, Wang YK, Jiang K, Gai XD. Sorbitol induces apoptosis of human colorectal cancer cells via p38 MAPK signal transduction. Oncol Lett 2014;7:1992-6. [PMID: 24932277 DOI: 10.3892/ol.2014.1994] [Cited by in Crossref: 22] [Cited by in F6Publishing: 26] [Article Influence: 2.8] [Reference Citation Analysis]
42 Rasool S, Rasool V, Naqvi T, Ganai BA, Shah BA. Genetic unraveling of colorectal cancer. Tumour Biol. 2014;35:5067-5082. [PMID: 24573608 DOI: 10.1007/s13277-014-1713-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
43 Qiu Y, Cai G, Zhou B, Li D, Zhao A, Xie G, Li H, Cai S, Xie D, Huang C, Ge W, Zhou Z, Xu LX, Jia W, Zheng S, Yen Y. A distinct metabolic signature of human colorectal cancer with prognostic potential. Clin Cancer Res. 2014;20:2136-2146. [PMID: 24526730 DOI: 10.1158/1078-0432.ccr-13-1939] [Cited by in Crossref: 92] [Cited by in F6Publishing: 102] [Article Influence: 11.5] [Reference Citation Analysis]
44 Skandarajah AR, Moritz RL, Tjandra JJ, Simpson RJ. Proteomic analysis of colorectal cancer: discovering novel biomarkers. Expert Review of Proteomics 2014;2:681-92. [DOI: 10.1586/14789450.2.5.681] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
45 Berardinelli F, di Masi A, Antoccia A. NBN Gene Polymorphisms and Cancer Susceptibility: A Systemic Review. Curr Genomics 2013;14:425-40. [PMID: 24396275 DOI: 10.2174/13892029113146660012] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
46 Re M, Santarelli A, Mascitti M, Bambini F, Lo Muzio L, Zizzi A, Rubini C. Trail overexpression inversely correlates with histological differentiation in intestinal-type sinonasal adenocarcinoma. Int J Surg Oncol 2013;2013:203873. [PMID: 24223304 DOI: 10.1155/2013/203873] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
47 Hammoudi A, Song F, Reed KR, Jenkins RE, Meniel VS, Watson AJ, Pritchard DM, Clarke AR, Jenkins JR. Proteomic profiling of a mouse model of acute intestinal Apc deletion leads to identification of potential novel biomarkers of human colorectal cancer (CRC). Biochem Biophys Res Commun. 2013;440:364-370. [PMID: 23998936 DOI: 10.1016/j.bbrc.2013.08.076] [Cited by in Crossref: 18] [Cited by in F6Publishing: 25] [Article Influence: 2.0] [Reference Citation Analysis]
48 Boursi B, Sella T, Liberman E, Shapira S, David M, Kazanov D, Arber N, Kraus S. The APC p.I1307K polymorphism is a significant risk factor for CRC in average risk Ashkenazi Jews. Eur J Cancer 2013;49:3680-5. [PMID: 23896379 DOI: 10.1016/j.ejca.2013.06.040] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 2.9] [Reference Citation Analysis]
49 Sameer AS. Colorectal cancer: molecular mutations and polymorphisms. Front Oncol. 2013;3:114. [PMID: 23717813 DOI: 10.3389/fonc.2013.00114] [Cited by in Crossref: 68] [Cited by in F6Publishing: 75] [Article Influence: 7.6] [Reference Citation Analysis]
50 Weng Y, Kong X, Yu Y, Wang Y, Hong J, Zhao S, Fang J. The role of ERK2 in colorectal carcinogenesis is partly regulated by TRAPPC4: TRAPPC4 PARTLY REGULATE ERK2 IN CRC. Mol Carcinog 2014;53:E72-84. [DOI: 10.1002/mc.22031] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
51 Zhao Y, Han Y, Zhang L, Wang Y, Ma Y, Zhang F, Fu D, Wang X. Quantitative assessment of the effect of cytochrome P450 2C9 gene polymorphism and colorectal cancer. PLoS One 2013;8:e60607. [PMID: 23577132 DOI: 10.1371/journal.pone.0060607] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
52 Shtilbans V. Role of stromal-epithelial interaction in the formation and development of cancer cells. Cancer Microenviron 2013;6:193-202. [PMID: 23430817 DOI: 10.1007/s12307-013-0131-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
53 Sameer AS. Colorectal cancer: a researcher’s perspective of the molecular angel’s gone eccentric in the Vale of Kashmir. Tumor Biol 2013;34:1301-15. [DOI: 10.1007/s13277-013-0692-4] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
54 Wang Y, Yang H, Li L, Xia X. An updated meta-analysis on the association of TGF-β1 gene promoter -509C/T polymorphism with colorectal cancer risk. Cytokine 2013;61:181-7. [PMID: 23084539 DOI: 10.1016/j.cyto.2012.09.014] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
55 Mathivanan S, Ji H, Tauro BJ, Chen YS, Simpson RJ. Identifying mutated proteins secreted by colon cancer cell lines using mass spectrometry. J Proteomics 2012;76 Spec No.:141-9. [PMID: 22796352 DOI: 10.1016/j.jprot.2012.06.031] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 3.8] [Reference Citation Analysis]
56 Huang Q, Huang JF, Zhang B, Baum L, Fu WL. Methylation variable position profiles of hMLH1 promoter CpG islands in human sporadic colorectal carcinoma. Diagn Mol Pathol 2012;21:24-33. [PMID: 22306672 DOI: 10.1097/PDM.0b013e318230effd] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
57 Choong MK, Tsafnat G. Genetic and Epigenetic Biomarkers of Colorectal Cancer. Clinical Gastroenterology and Hepatology 2012;10:9-15. [DOI: 10.1016/j.cgh.2011.04.020] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 2.8] [Reference Citation Analysis]
58 Re M, Magliulo G, Tarchini P, Mallardi V, Rubini C, Santarelli A, Lo Muzio L. p53 and BCL-2 over-expression inversely correlates with histological differentiation in occupational ethmoidal intestinal-type sinonasal adenocarcinoma. Int J Immunopathol Pharmacol 2011;24:603-9. [PMID: 21978692 DOI: 10.1177/039463201102400306] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
59 Wang Y, Yang H, Li L, Wang H, Zhang C, Xia X. E-cadherin (CDH1) gene promoter polymorphism and the risk of colorectal cancer : a meta-analysis. Int J Colorectal Dis 2012;27:151-8. [PMID: 21997289 DOI: 10.1007/s00384-011-1320-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
60 Shahmoradi S, Bidmeshkipour A, Salamian A, Emami MH, Kazemi Z, Salehi M. Two novel mutations in hMLH1 gene in Iranian hereditary non-polyposis colorectal cancer patients. Familial Cancer 2012;11:13-7. [DOI: 10.1007/s10689-011-9478-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
61 Amin S, McBride RB, Kline JK, Mitchel EB, Lucas AL, Neugut AI, Frucht H. Incidence of subsequent pancreatic adenocarcinoma in patients with a history of nonpancreatic primary cancers. Cancer 2012;118:1244-51. [PMID: 21887676 DOI: 10.1002/cncr.26414] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
62 Zhao SL, Hong J, Xie ZQ, Tang JT, Su WY, Du W, Chen YX, Lu R, Sun DF, Fang JY. TRAPPC4-ERK2 interaction activates ERK1/2, modulates its nuclear localization and regulates proliferation and apoptosis of colorectal cancer cells. PLoS One. 2011;6:e23262. [PMID: 21826244 DOI: 10.1371/journal.pone.0023262] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 1.8] [Reference Citation Analysis]
63 Rasuck CG, Leite SM, Komatsuzaki F, Ferreira AC, Oliveira VC, Gomes KB. Association between methylation in mismatch repair genes, V600E BRAF mutation and microsatellite instability in colorectal cancer patients. Mol Biol Rep 2012;39:2553-60. [PMID: 21681432 DOI: 10.1007/s11033-011-1007-8] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
64 Thakral NK, Ray AR, Bar-Shalom D, Eriksson AH, Majumdar DK. The quest for targeted delivery in colon cancer: mucoadhesive valdecoxib microspheres. Int J Nanomedicine 2011;6:1057-68. [PMID: 21720517 DOI: 10.2147/IJN.S19561] [Cited by in Crossref: 17] [Cited by in F6Publishing: 23] [Article Influence: 1.5] [Reference Citation Analysis]
65 Boverhof DR, Chamberlain MP, Elcombe CR, Gonzalez FJ, Heflich RH, Hernández LG, Jacobs AC, Jacobson-Kram D, Luijten M, Maggi A, Manjanatha MG, Benthem Jv, Gollapudi BB. Transgenic animal models in toxicology: historical perspectives and future outlook. Toxicol Sci 2011;121:207-33. [PMID: 21447610 DOI: 10.1093/toxsci/kfr075] [Cited by in Crossref: 70] [Cited by in F6Publishing: 52] [Article Influence: 6.4] [Reference Citation Analysis]
66 Kalimutho M, Blanco Gdel V, Gravina P, Cretella M, Mannucci L, Mannisi E, Formosa A, Pallone F, Federici G, Bernardini S. Quantitative denaturing high performance liquid chromatography (Q-dHPLC) detection of APC long DNA in faeces from patients with colorectal cancer. Clin Chem Lab Med. 2010;48:1303-1311. [PMID: 20504269 DOI: 10.1515/cclm.2010.245] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
67 Rosser CJ, Goodison S. Today's discoveries to tomorrow's care: cancer biomarkers revisited. Foreword. Biomark Med 2010;4:491-3. [PMID: 20701437 DOI: 10.2217/bmm.10.78] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
68 Parveen N, Hussain MU, Pandith AA, Mudassar S. Diversity of axin in signaling pathways and its relation to colorectal cancer. Med Oncol 2011;28:259-67. [DOI: 10.1007/s12032-010-9722-x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
69 Bansal A, Singh V, Liu X, Mcgregor DH, Hall S. Correlation of Epidermal Growth Factor Receptor With Morphological Features of Colorectal Advanced Adenomas: A Pilot Correlative Case Series. The American Journal of the Medical Sciences 2010;340:296-300. [DOI: 10.1097/maj.0b013e3181e7fbf3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
70 Erreni M, Mantovani A, Allavena P. Tumor-associated Macrophages (TAM) and Inflammation in Colorectal Cancer. Cancer Microenviron. 2011;4:141-154. [PMID: 21909876 DOI: 10.1007/s12307-010-0052-5] [Cited by in Crossref: 205] [Cited by in F6Publishing: 214] [Article Influence: 17.1] [Reference Citation Analysis]
71 Sameer AS, Chowdri NA, Syeed N, Banday MZ, Shah ZA, Siddiqi MA. SMAD4--molecular gladiator of the TGF-beta signaling is trampled upon by mutational insufficiency in colorectal carcinoma of Kashmiri population: an analysis with relation to KRAS proto-oncogene. BMC Cancer 2010;10:300. [PMID: 20565773 DOI: 10.1186/1471-2407-10-300] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
72 Huynh N, Liu KH, Baldwin GS, He H. P21-activated kinase 1 stimulates colon cancer cell growth and migration/invasion via ERK- and AKT-dependent pathways. Biochim Biophys Acta. 2010;1803:1106-1113. [PMID: 20595063 DOI: 10.1016/j.bbamcr.2010.05.007] [Cited by in Crossref: 69] [Cited by in F6Publishing: 69] [Article Influence: 5.8] [Reference Citation Analysis]
73 Park J, Conteas CN. Anti-carcinogenic properties of curcumin on colorectal cancer. World J Gastrointest Oncol 2010; 2(4): 169-176 [PMID: 21160593 DOI: 10.4251/wjgo.v2.i4.169] [Cited by in CrossRef: 46] [Cited by in F6Publishing: 40] [Article Influence: 3.8] [Reference Citation Analysis]
74 Tang NP, Wu YM, Wang B, Ma J. Systematic review and meta-analysis of the association between P53 codon 72 polymorphism and colorectal cancer. Eur J Surg Oncol. 2010;36:431-438. [PMID: 20363586 DOI: 10.1016/j.ejso.2010.03.010] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 1.8] [Reference Citation Analysis]
75 Baer HJ, Brawarsky P, Murray MF, Haas JS. Familial risk of cancer and knowledge and use of genetic testing. J Gen Intern Med 2010;25:717-24. [PMID: 20361271 DOI: 10.1007/s11606-010-1334-9] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 1.9] [Reference Citation Analysis]
76 Pellegrini ML, Argibay P, Gomez DE. Dietary factors, genetic and epigenetic influences in colorectal cancer. Exp Ther Med 2010;1:241-50. [PMID: 22993535 DOI: 10.3892/etm_00000038] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
77 Holt PR, Kozuch P, Mewar S. Colon cancer and the elderly: from screening to treatment in management of GI disease in the elderly. Best Pract Res Clin Gastroenterol. 2009;23:889-907. [PMID: 19942166 DOI: 10.1016/j.bpg.2009.10.010] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 2.2] [Reference Citation Analysis]
78 Hoff JH, Morsche RHT, Roelofs HM, Logt EMVD, Nagengast FM, Peters WH. COX-2 polymorphisms -765G→C and -1195A→G and colorectal cancer risk. World J Gastroenterol 2009; 15(36): 4561-4565 [PMID: 19777615 DOI: 10.3748/wjg.15.4561] [Cited by in CrossRef: 28] [Cited by in F6Publishing: 25] [Article Influence: 2.2] [Reference Citation Analysis]
79 Hernández LG, van Steeg H, Luijten M, van Benthem J. Mechanisms of non-genotoxic carcinogens and importance of a weight of evidence approach. Mutation Research/Reviews in Mutation Research 2009;682:94-109. [DOI: 10.1016/j.mrrev.2009.07.002] [Cited by in Crossref: 156] [Cited by in F6Publishing: 134] [Article Influence: 12.0] [Reference Citation Analysis]
80 Nibbe RK, Chance MR. Approaches to biomarkers in human colorectal cancer: looking back, to go forward. Biomark Med. 2009;3:385-396. [PMID: 20161020 DOI: 10.2217/bmm.09.33] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
81 Tóth K, Galamb O, Spisák S, Wichmann B, Sipos F, Leiszter K, Molnár J, Molnár B, Tulassay Z. [Free circulating DNA based colorectal cancer screening from peripheral blood: the possibility of the methylated septin 9 gene marker]. Orv Hetil 2009;150:969-77. [PMID: 19443305 DOI: 10.1556/OH.2009.28625] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
82 Zauber NP, Marotta SP, Berman E, Grann A, Rao M, Komati N, Ribiero K, Bishop DT. Molecular genetic changes associated with colorectal carcinogenesis are not prognostic for tumor regression following preoperative chemoradiation of rectal carcinoma. Int J Radiat Oncol Biol Phys 2009;74:472-6. [PMID: 19304403 DOI: 10.1016/j.ijrobp.2008.08.020] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.5] [Reference Citation Analysis]
83 Richter S. Fecal DNA screening in colorectal cancer. Can J Gastroenterol 2008;22:631-3. [PMID: 18629393 DOI: 10.1155/2008/761208] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
84 Macartney-Coxson DP, Hood KA, Shi HJ, Ward T, Wiles A, O'Connor R, Hall DA, Lea RA, Royds JA, Stubbs RS, Rooker S. Metastatic susceptibility locus, an 8p hot-spot for tumour progression disrupted in colorectal liver metastases: 13 candidate genes examined at the DNA, mRNA and protein level. BMC Cancer 2008;8:187. [PMID: 18590575 DOI: 10.1186/1471-2407-8-187] [Cited by in Crossref: 60] [Cited by in F6Publishing: 65] [Article Influence: 4.3] [Reference Citation Analysis]
85 Zhu ZZ, Wang AZ, Jia HR, Jin XX, He XL, Hou LF, Zhu G. Association of the TP53 codon 72 polymorphism with colorectal cancer in a Chinese population. Jpn J Clin Oncol. 2007;37:385-390. [PMID: 17599946 DOI: 10.1093/jjco/hym034] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 2.7] [Reference Citation Analysis]
86 Al-Saleh I, Arif J, El-Doush I, Al-Sanea N, Jabbar AA, Billedo G, Shinwari N, Mashhour A, Mohamed G. Carcinogen DNA adducts and the risk of colon cancer: case-control study. Biomarkers 2008;13:201-16. [PMID: 18270871 DOI: 10.1080/13547500701775449] [Cited by in F6Publishing: 10] [Reference Citation Analysis]
87 Gout S, Huot J. Role of cancer microenvironment in metastasis: focus on colon cancer. Cancer Microenviron. 2008;1:69-83. [PMID: 19308686 DOI: 10.1007/s12307-008-0007-2] [Cited by in Crossref: 108] [Cited by in F6Publishing: 116] [Article Influence: 7.7] [Reference Citation Analysis]
88 Ponz de Leon M, Bertario L, Genuardi M, Lanza G, Oliani C, Ranzani GN, Rossi GB, Varesco L, Venesio T, Viel A. Identification and Classification of Hereditary Nonpolyposis Colorectal Cancer (Lynch Syndrome): Adapting Old Concepts to Recent Advancements. Report from the Italian Association for the Study of Hereditary Colorectal Tumors Consensus Group. Diseases of the Colon & Rectum 2007;50:2126-34. [DOI: 10.1007/s10350-007-9071-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 0.5] [Reference Citation Analysis]
89 Pardini B, Naccarati A, Novotny J, Smerhovsky Z, Vodickova L, Polakova V, Hanova M, Slyskova J, Tulupova E, Kumar R. DNA repair genetic polymorphisms and risk of colorectal cancer in the Czech Republic. Mutat Res. 2008;638:146-153. [PMID: 17991492 DOI: 10.1016/j.mrfmmm.2007.09.008] [Cited by in Crossref: 81] [Cited by in F6Publishing: 84] [Article Influence: 5.4] [Reference Citation Analysis]
90 Kan T, Paun BC, Mori Y, Sato F, Jin Z, Hamilton JP, Ito T, Cheng Y, David S, Olaru AV, Yang J, Agarwal R, Abraham JM, Meltzer SJ. Rarity of Somatic Mutation and Frequency of Normal Sequence Variation Detected in Sporadic Colon Adenocarcinoma Using High-Throughput cDNA Sequencing. Bioinform Biol Insights 2007;1:117793220700100. [DOI: 10.1177/117793220700100001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
91 Chu DZ, Gibson G, David D, Yen Y. The surgeon's role in cancer prevention. The model in colorectal carcinoma. Ann Surg Oncol 2007;14:3054-69. [PMID: 17710500 DOI: 10.1245/s10434-007-9485-6] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
92 Bates RC, Pursell BM, Mercurio AM. Epithelial-Mesenchymal Transition and Colorectal Cancer: Gaining Insights into Tumor Progression Using LIM 1863 Cells. Cells Tissues Organs 2007;185:29-39. [DOI: 10.1159/000101300] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 2.1] [Reference Citation Analysis]
93 Suzuki R, Miyamoto S, Yasui Y, Sugie S, Tanaka T. Global gene expression analysis of the mouse colonic mucosa treated with azoxymethane and dextran sodium sulfate. BMC Cancer. 2007;7:84. [PMID: 17506908 DOI: 10.1186/1471-2407-7-84] [Cited by in Crossref: 43] [Cited by in F6Publishing: 51] [Article Influence: 2.9] [Reference Citation Analysis]
94 De Miglio MR, Virdis P, Calvisi DF, Mele D, Muroni MR, Frau M, Pinna F, Tomasi ML, Simile MM, Pascale RM, Feo F. Identification and chromosome mapping of loci predisposing to colorectal cancer that control Wnt/beta-catenin pathway and progression of early lesions in the rat. Carcinogenesis 2007;28:2367-74. [PMID: 17510081 DOI: 10.1093/carcin/bgm119] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
95 Johnson JJ, Mukhtar H. Curcumin for chemoprevention of colon cancer. Cancer Lett 2007;255:170-81. [PMID: 17448598 DOI: 10.1016/j.canlet.2007.03.005] [Cited by in Crossref: 261] [Cited by in F6Publishing: 231] [Article Influence: 17.4] [Reference Citation Analysis]
96 Basso D, Navaglia F, Fogar P, Zambon CF, Greco E, Schiavon S, Fasolo M, Stranges A, Falda A, Padoan A. DNA repair pathways and mitochondrial DNA mutations in gastrointestinal carcinogenesis. Clin Chim Acta. 2007;381:50-55. [PMID: 17397816 DOI: 10.1016/j.cca.2007.02.020] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 2.1] [Reference Citation Analysis]
97 Kodama K, Mizuno T, Imahori T, Ida M, Matsubara F. Concurrent diagnosis of urothelial carcinoma and squamous cell carcinoma of the bladder in a patient with a vesicorectal fistula from invasive rectal cancer. Int J Urol 2006;13:296-8. [PMID: 16643630 DOI: 10.1111/j.1442-2042.2006.01287.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
98 Ponti G, Losi L, Pedroni M, Lucci-cordisco E, Di Gregorio C, Pellacani G, Seidenari S. Value of MLH1 and MSH2 Mutations in the Appearance of Muir–Torre Syndrome Phenotype in HNPCC Patients Presenting Sebaceous Gland Tumors or Keratoacanthomas. Journal of Investigative Dermatology 2006;126:2302-7. [DOI: 10.1038/sj.jid.5700475] [Cited by in Crossref: 77] [Cited by in F6Publishing: 64] [Article Influence: 4.8] [Reference Citation Analysis]
99 Baker SG, Kaprio J. Common susceptibility genes for cancer: search for the end of the rainbow. BMJ 2006;332:1150-2. [PMID: 16690677 DOI: 10.1136/bmj.332.7550.1150] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
100 Pérez LO, Abba MC, Dulout FN, Golijow CD. Evaluation of p53 codon 72 polymorphism in adenocarcinomas of the colon and rectum in La Plata, Argentina. World J Gastroenterol 2006; 12(9): 1426-1429 [PMID: 16552814 DOI: 10.3748/wjg.v12.i9.1426] [Cited by in CrossRef: 45] [Cited by in F6Publishing: 43] [Article Influence: 2.8] [Reference Citation Analysis]
101 Arnold CN, Goel A, Blum HE, Boland CR. Molecular pathogenesis of colorectal cancer: implications for molecular diagnosis. Cancer 2005;104:2035-47. [PMID: 16206296 DOI: 10.1002/cncr.21462] [Cited by in Crossref: 95] [Cited by in F6Publishing: 89] [Article Influence: 5.9] [Reference Citation Analysis]
102 Ferron M, Praz F, Pocard M. Génétique du cancer colorectal. Annales de Chirurgie 2005;130:602-7. [DOI: 10.1016/j.anchir.2005.02.014] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
103 Chen AL, Soman KV, Rychahou PG, Luxon BA, Evers BM. Proteomic analysis of colonic myofibroblasts and effect on colon cancer cell proliferation. Surgery 2005;138:382-90. [PMID: 16153451 DOI: 10.1016/j.surg.2005.04.012] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 0.6] [Reference Citation Analysis]
104 Canter RJ, Kesmodel SB, Heitjan DF, Veeramachaneni NK, Mokadam NA, Drebin JA, Fraker DL. Suppression of beta-catenin by antisense oligomers augments tumor response to isolated limb perfusion in a rodent model of adenomatous polyposis coli-mutant colon cancer. Ann Surg Oncol 2005;12:733-42. [PMID: 16132380 DOI: 10.1245/ASO.2005.10.005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
105 Young Y, Terdiman JP. Endoscopic Management of Familial Colonic Neoplasia. Gastrointestinal Endoscopy Clinics of North America 2005;15:549-80. [DOI: 10.1016/j.giec.2005.03.007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
106 Baker SG, Lichtenstein P, Kaprio J, Holm N. Genetic susceptibility to prostate, breast, and colorectal cancer among Nordic twins. Biometrics 2005;61:55-63. [PMID: 15737078 DOI: 10.1111/j.0006-341X.2005.030924.x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 25] [Article Influence: 1.9] [Reference Citation Analysis]
107 van Kouwen MC, Nagengast FM, Jansen JB, Oyen WJ, Drenth JP. 2-(18F)-fluoro-2-deoxy-D-glucose positron emission tomography detects clinical relevant adenomas of the colon: a prospective study. J Clin Oncol 2005;23:3713-7. [PMID: 15923568 DOI: 10.1200/JCO.2005.02.401] [Cited by in Crossref: 70] [Cited by in F6Publishing: 55] [Article Influence: 4.1] [Reference Citation Analysis]
108 Fang JY, Richardson BC. The MAPK signalling pathways and colorectal cancer. Lancet Oncol. 2005;6:322-327. [PMID: 15863380 DOI: 10.1016/s1470-2045(05)70168-6] [Cited by in Crossref: 467] [Cited by in F6Publishing: 531] [Article Influence: 27.5] [Reference Citation Analysis]
109 Sugiyama Y, Farrow B, Murillo C, Li J, Watanabe H, Sugiyama K, Evers BM. Analysis of differential gene expression patterns in colon cancer and cancer stroma using microdissected tissues. Gastroenterology 2005;128:480-6. [PMID: 15685558 DOI: 10.1053/j.gastro.2004.11.010] [Cited by in Crossref: 38] [Cited by in F6Publishing: 35] [Article Influence: 2.2] [Reference Citation Analysis]
110 Matloff ET, Brierley KL, Chimera CM. A clinician's guide to hereditary colon cancer. Cancer J 2004;10:280-7. [PMID: 15530254 DOI: 10.1097/00130404-200409000-00002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
111 Weitz J, Koch M, Debus J, Höhler T, Galle PR, Büchler MW. Colorectal cancer. Lancet. 2005;365:153-165. [PMID: 15639298 DOI: 10.1016/s0140-6736(05)17706-x] [Cited by in Crossref: 744] [Cited by in F6Publishing: 756] [Article Influence: 43.8] [Reference Citation Analysis]
112 Perez-Ordonez B, Huynh NN, Berean KW, Jordan RC. Expression of mismatch repair proteins, beta catenin, and E cadherin in intestinal-type sinonasal adenocarcinoma. J Clin Pathol 2004;57:1080-3. [PMID: 15452164 DOI: 10.1136/jcp.2004.018051] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 1.6] [Reference Citation Analysis]
113 Mitchell MK, Gregersen PK, Johnson S, Parsons R, Vlahov D; New York Cancer Project. The New York Cancer Project: rationale, organization, design, and baseline characteristics. J Urban Health 2004;81:301-10. [PMID: 15136663 DOI: 10.1093/jurban/jth116] [Cited by in Crossref: 73] [Cited by in F6Publishing: 73] [Article Influence: 4.1] [Reference Citation Analysis]
114 Feskanich D, Ma J, Fuchs CS, Kirkner GJ, Hankinson SE, Hollis BW, Giovannucci EL. Plasma Vitamin D Metabolites and Risk of Colorectal Cancer in Women. Cancer Epidemiology, Biomarkers & Prevention 2004;13:1502-8. [DOI: 10.1158/1055-9965.1502.13.9] [Cited by in Crossref: 18] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
115 Liu Y, Su W, Thompson EA, Leitges M, Murray NR, Fields AP. Protein kinase CbetaII regulates its own expression in rat intestinal epithelial cells and the colonic epithelium in vivo. J Biol Chem 2004;279:45556-63. [PMID: 15322124 DOI: 10.1074/jbc.M407701200] [Cited by in Crossref: 46] [Cited by in F6Publishing: 39] [Article Influence: 2.6] [Reference Citation Analysis]
116 Moran AE, Hunt DH, Javid SH, Redston M, Carothers AM, Bertagnolli MM. Apc deficiency is associated with increased Egfr activity in the intestinal enterocytes and adenomas of C57BL/6J-Min/+ mice. J Biol Chem 2004;279:43261-72. [PMID: 15294912 DOI: 10.1074/jbc.M404276200] [Cited by in Crossref: 78] [Cited by in F6Publishing: 74] [Article Influence: 4.3] [Reference Citation Analysis]
117 Ponz de Leon M, Benatti P, Di Gregorio C, Pedroni M, Losi L, Genuardi M, Viel A, Fornasarig M, Lucci-Cordisco E, Anti M. Genetic testing among high-risk individuals in families with hereditary nonpolyposis colorectal cancer. Br J Cancer. 2004;90:882-887. [PMID: 14970868 DOI: 10.1038/sj.bjc.6601529] [Cited by in Crossref: 45] [Cited by in F6Publishing: 49] [Article Influence: 2.5] [Reference Citation Analysis]
118 Berger BM, Vucson BM, Ditelberg JS. Gene mutations in advanced colonic polyps: potential marker selection for stool-based mutated human DNA assays for colon cancer screening. Clin Colorectal Cancer 2003;3:180-5. [PMID: 14706178 DOI: 10.3816/CCC.2003.n.024] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
119 Zhang J, Anastasiadis PZ, Liu Y, Thompson EA, Fields AP. Protein kinase C (PKC) betaII induces cell invasion through a Ras/Mek-, PKC iota/Rac 1-dependent signaling pathway. J Biol Chem 2004;279:22118-23. [PMID: 15037605 DOI: 10.1074/jbc.M400774200] [Cited by in Crossref: 109] [Cited by in F6Publishing: 95] [Article Influence: 6.1] [Reference Citation Analysis]
120 Kirstein SL, Insel PA. Autonomic Nervous System Pharmacogenomics: A Progress Report. Pharmacol Rev 2004;56:31-52. [DOI: 10.1124/pr.56.1.2] [Cited by in Crossref: 96] [Cited by in F6Publishing: 84] [Article Influence: 5.3] [Reference Citation Analysis]
121 Wang Y, Gong SG, Zhang WG, Chen JH, Zhang LY, Chen JP. Sensitivity and specificity of pneumo-colon CT in detecting colorectal neoplasms. Shijie Huaren Xiaohua Zazhi 2004; 12(2): 359-362 [DOI: 10.11569/wcjd.v12.i2.359] [Reference Citation Analysis]
122 Monstein H, Fransen K, Dimberg J, Soderkvist P. K-ras and B-raf gene mutations are not associated with gastrin- and CCK2-receptor mRNA expression in human colorectal tumour tissues. Eur J Clin Invest 2004;34:100-6. [DOI: 10.1111/j.1365-2362.2004.01296.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
123 Itzkowitz S. Colon carcinogenesis in inflammatory bowel disease: applying molecular genetics to clinical practice. J Clin Gastroenterol. 2003;36:S70-S4; discussion S94-6. [PMID: 12702969 DOI: 10.1097/00004836-200305001-00012] [Cited by in Crossref: 56] [Cited by in F6Publishing: 52] [Article Influence: 2.9] [Reference Citation Analysis]
124 Burger-Weiser G, Waterhouse L, Richter S, Kitchen CM. Increased frequency of colon polyps leading to colon cancer among women. Arch Med Res 2003;34:152-3. [PMID: 12700014 DOI: 10.1016/S0188-4409(02)00471-X] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]